FCCC Faculty Publications

Zhu Y, Alonso DO, Maki K, Huang CY, Lahr SJ, Daggett V, Roder H, DeGrado WF, Gai F. Ultrafast folding of alpha3D: a de novo designed three-helix bundle protein. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26) :15486-91.

Daganzo SM, Erzberger JP, Lam WM, Skordalakes E, Zhang R, Franco AA, Brill SJ, Adams PD, Berger JM, Kaufman PD. Structure and function of the conserved core of histone deposition protein Asf1. Curr Biol. 2003 Dec 16;13(24) :2148-58.

Dadke D, Fryer BH, Golemis EA, Field J. Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation. Cancer Res. 2003 Dec 15;63(24) :8837-47.

Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer. 2003 Dec 10;107(5) :797-803.

Cortellino S, Turner D, Masciullo V, Schepis F, Albino D, Daniel R, Skalka AM, Meropol NJ, Alberti C, Larue L, Bellacosa A. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25) :15071-6. PMC ID:PMC299910.

Van Horn L, Obarzanek E, Barton BA, Stevens VJ, Kwiterovich PO Jr, Lasser NL, Robson AM, Franklin FA Jr, Lauer RM, Kimm SY, Dorgan JF, Greenlick MR. A summary of results of the Dietary Intervention Study in Children (DISC): lessons learned. Prog Cardiovasc Nurs. 2003 Winter;18(1) :28-41.

Young RC, Brady MF, Nieberg RK, Long HJ, Mayer AR, Lentz SS, Hurteau J, Alberts DS. Adjuvant treatment for early ovarian cancer: A randomized phase III trial of intraperitoneal P-32 or intravenous cyclophosphamide and cisplatin - A gynecologic oncology group study. Journal of Clinical Oncology. 2003 Dec;21(23) :4350-4355.

Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SHE. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. Journal of Pathology. 2003 Dec;201(4) :581-588.

Lui YW, Macari M, Israel G, Bini EJ, Wang H, Babb J. CT colonography data interpretation: Effect of different section thicknesses - Preliminary observations. Radiology. 2003 Dec;229(3) :791-797.

Knudson AG. Cancer genetics through a personal retrospectroscope. Genes Chromosomes Cancer. 2003 Dec;38(4) :288-291.

Astrinidis A, Senapedis W, Coleman TR, Henske EP. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1 cyclin B. Journal of Biological Chemistry. 2003 Dec;278(51) :51372-51379.

Wu H, Smith M, Millenson MM, Nicolaou N, Van Deerlin VM, Addya K, Lessin S, Al-Saleem T. Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions. Journal of Investigative Dermatology. 2003 Dec;121(6) :1522-1530.

Serna A, Ramirez MC, Soukhanova A, Sigal LJ. Cutting edge: Efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. Journal of Immunology. 2003 Dec;171(11) :5668-5672.

Kruger WD, Wang L, Jhee KH, Singh RH, Elsas LJ. Cystathionine beta-synthase deficiency in Georgia (USA): Correlation of clinical and biochemical phenotype with genotype. Human Mutation. 2003 Dec;22(6) :434-441.

Guo P, Ma JG, Li SL, Gallo JM. Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2003 Dec;798(1) :79-86.

Bellacosa A. Genetic hits and mutation rate in colorectal tumorigenesis: versatility of Knudson's theory and implications for cancer prevention. Genes Chromosomes Cancer. 2003 Dec;38(4) :382-8.

Schleutker J, Baffoe-Bonnie AB, Gillanders E, Kainu T, Jones MP, Freas-Lutz D, Markey C, Gildea D, Riedesel E, Albertus J, Gibbs KD Jr, Matikainen M, Koivisto PA, Tammela T, Bailey-Wilson JE, Trent JM, Kallioniemi OP. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate. 2003 Dec 1;57(4) :280-9.

Kuban D, Pollack A, Huang E, Levy L, Dong L, Starkschall G, Rosen I. Hazards of dose escalation in prostate cancer radiotherapy. International Journal of Radiation Oncology Biology Physics. 2003 Dec;57(5) :1260-1268.

Katz RA, Greger JG, Boimel P, Skalka AM. Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells. Journal of Virology. 2003 Dec;77(24) :13412-13417.

Pollack A, Taylor N, Kelly JF, Kuban DA, Pisters LL. In response to Drs. Lawrence and Crawford. International Journal of Radiation Oncology Biology Physics. 2003 Dec;57(5) :1511-1511.

Fourkal E, Li JS, Xiong W, Nahum A, Ma CM. Intensity modulated radiation therapy using laser-accelerated protons: a Monte Carlo dosimetric study. Physics in Medicine and Biology. 2003 Dec;48(24) :3977-4000.

Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CDM, Silberman S, Dimitrijevic S, Fletcher JA. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. Journal of Clinical Oncology. 2003 Dec;21(23) :4342-4349.

Roland IH, Yang WL, Yang DH, Daly MB, Ozols RF, Hamilton TC, Lynch HT, Godwin AK, Xu XX. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer. 2003 Dec;98(12) :2607-2623.

Henske EP. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosomes Cancer. 2003 Dec;38(4) :376-81.

Subhi AL, Diegelman P, Porter CW, Tang BQ, Lu ZCJ, Markham GD, Kruger WD. Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites. Journal of Biological Chemistry. 2003 Dec;278(50) :49868-49873.

Xiao GH, Chernoff J, Testa JR. NF2: The wizardry of merlin. Genes Chromosomes Cancer. 2003 Dec;38(4) :389-99.

Kuwata K, Matumoto T, Cheng H, Nagayama K, James TL, Roder H. NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proceedings of the National Academy of Sciences of the United States of America. 2003 Dec;100(25) :14790-14795.

Manne S, DuHamel K, Winkel G, Ostroff J, Parsons S, Martini R, Williams SE, Mee L, Austin J, Redd WH. Perceived partner critical and avoidant behaviors as predictors of anxious and depressive symptoms among mothers of children undergoing hemopaietic stem cell transplantation. J Consult Clin Psychol. 2003 Dec;71(6) :1076-83.

Trotman Lloyd C, Niki Masaru, Dotan Zohar A, Koutcher Jason A, Di Cristofano Antonio, Xiao Andrew, Khoo Alan S, Roy-Burman Pradip, Greenberg Norman M, Dyke Terry Van, Cordon-Cardo Carlos, Pandolfi Pier Paolo. Pten Dose Dictates Cancer Progression in the Prostate. PLoS Biology. 2003 December 1, 2003;1(3) :e59.

Sharkey RM, Brenner A, Burton J, Hajjar G, Toder SP, Alavi A, Matthies A, Tsai DE, Schuster SJ, Stadtmauer EA, Czuczman MS, Lamonica D, Kraeber-Bodere F, Mahe B, Chatal JF, Rogatko A, Mardirrosian G, Goldenberg DM. Radioimmunotherapy of non-Hodgkin's lymphoma with Y-90-DOTA humanized Anti-CD22 IgG (Y-90-epratuzumab): Do tumor targeting and dosimetry predict therapeutic response?. Journal of Nuclear Medicine. 2003 Dec;44(12) :2000-2018.

Topham NS. Reconstruction for lower extremity limb salvage in soft tissue carcinoma. Curr Treat Options Oncol. 2003 Dec;4(6) :465-75.

Harris RA, Chen G, Lin WY, Shen FM, London WT, Evans AA. Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population. Cancer Causes & Control. 2003 Dec;14(10) :995-1000.

Cohen S, Hamrick N. Stable individual differences in physiological response to stressors: implications for stress-elicited changes in immune related health. Brain Behavior and Immunity. 2003 Dec;17(6) :407-414.

Yang DH, Moss EG. Temporally regulated expression of Lin-28 in diverse tissues. Gene Expression Patterns. 2003 Dec;3(6) :719-726.

Lanza-Jacoby S, Miller S, Flynn J, Gallatig K, Daskalakis C, Masferrer JL, Zweifel BS, Sembhi H, Russo IH. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in HER-2/neu mice. Cancer Epidemiology Biomarkers & Prevention. 2003 Dec;12(12) :1486-1491.

Taylor JM. Therapy for HDV!. Hepatology. 2003 Dec;38(6) :1581-2.

Testa JR, Hino O. Tumor suppressor genes and the two-hit model of recessive oncogenesis: Celebrating Alfred Knudson's 80th birthday. Genes Chromosomes Cancer. 2003 Dec;38(4) :286-287.

Licata A, Di Bona D, Schepis F, Shahied L, Craxi A, Camma C. When and how to treat acute hepatitis C?. Journal of Hepatology. 2003 Dec;39(6) :1056-1062.

Stead K, Aguilar C, Hartman T, Drexel M, Meluh P, Guacci V. Pds5p regulates the maintenance of sister chromatid cohesion and is sumoylated to promote the dissolution of cohesion. J Cell Biol. 2003 Nov 24;163(4) :729-41.

Johnston VK, Maley D, Gagnon RC, Grassmann CW, Behrens SE, Sarisky RT. Kinetic profile of a heterocyclic HCV replicon RNA synthesis inhibitor. Biochem Biophys Res Commun. 2003 Nov 21;311(3) :672-7.

Thames H, Kuban D, Levy L, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4) :929-43.

Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4) :915-28.

Isken O, Grassmann CW, Sarisky RT, Kann M, Zhang S, Grosse F, Kao PN, Behrens SE. Members of the NF90/NFAR protein group are involved in the life cycle of a positive-strand RNA virus. EMBO J. 2003 Nov 3;22(21) :5655-5665.

Price RA, Murphy S, McNeeley SW, Charlie CM, Horwitz E, Movsas B, Raben A, Pollack A. A method for increased dose conformity and segment reduction for sMLC delivered IMRT treatment of the prostate. International Journal of Radiation Oncology Biology Physics. 2003 Nov;57(3) :843-852.

Horwitz EM, Uzzo RG, Miller N, Theodorescu D. Brachytherapy for prostate cancer follow-up and management of treatment failures. Urologic Clinics of North America. 2003 Nov;30(4) :737--50, viii-ix..

Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Cervical cancer - Behavioral factors related to screening, diagnosis, and survivors' quality of life. Cancer. 2003 Nov;98(9) :2009-2014, Suppl. S.

Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New England Journal of Medicine. 2003 Nov;349(22) :2091-2098.

Lewis NL, Meropol NJ. Development of new agents for the treatment of advanced colorectal cancer. Clin Colorectal Cancer. 2003 Nov;3(3) :154-64.

Kreamer KM. Getting the lowdown on lung cancer. Nursing. 2003 Nov;33(11) :36-42; quiz 42-3.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D. Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. American Journal of Neuroradiology. 2003 Nov-Dec;24(10) :1989-1998.

Eisenberg BL. Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors. Oncology (Huntingt). 2003 Nov;17(11) :1615-20; discussion 1620, 1623, 1626 passim.

Hensley H, Pollack A. In vivo visualization of metastatic prostate cancer.[comment]. CM - Comment on: Cancer Biol Ther. 2003 Nov-Dec;2(6):656-60; PMID: 14688471. Cancer Biology & Therapy. 2003 Nov-Dec;2(6) :661-2.

Bookman MA, Greer BE, Ozols RF. Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG158) and an update on GOG0 182-ICON5. International Journal of Gynecological Cancer. 2003 Nov-Dec;13(6) :735-740.

Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02. Journal of Clinical Oncology. 2003 Nov;21(21) :3972-3978.

Fang CY, Miller SM, Malick J, Babb J, Engstrom PF, Daly MB. Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. Prev Med. 2003 Nov;37(5) :424-31.

Dong YS, Hakimi MA, Chen XW, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Molecular Cell. 2003 Nov;12(5) :1087-1099.

Roth MJ, Baer DJ, Albert PS, Castonguay TW, Dorgan JF, Dawsey SM, Brown ED, Hartman TJ, Campbell WS, Giffen CA, Judd JT, Taylor PR. Relationship between serum leptin levels and alcohol consumption in a controlled feeding and alcohol ingestion study. Journal of the National Cancer Institute. 2003 Nov;95(22) :1722-1725.

Chang JH, Provost P, Taylor JM. Resistance of human hepatitis delta virus RNAs to dicer activity. Journal of Virology. 2003 Nov;77(22) :11910-11917.

Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. Journal of Virology. 2003 Nov;77(22) :11992-12001.

Tapiero H, Townsend DM, Tew KD. Trace elements in human physiology and pathology. Copper. Biomedicine & Pharmacotherapy. 2003 Nov;57(9) :386-398.

Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomedicine & Pharmacotherapy. 2003 Nov;57(9) :399-411.

Mallory MJ, Strich R. Ume1p represses meiotic gene transcription in Saccharomyces cerevisiae through interaction with the histone deacetylase Rpd3p. Journal of Biological Chemistry. 2003 Nov;278(45) :44727-44734.

Haas NB, Giantonio BJ, Litwin S, Minniti CJ, Fox S, Yeslow G, Reilly R, Nahum K, Greenberg R, Halbherr T, Hudes GR. Vinblastine and estramustine phosphate in metastatic renal cell carcinoma - A phase II trial of the fox chase network. Cancer. 2003 Nov;98(9) :1837-1841.

Hammond E, Berkey BA, Fu KK, Trotti A, Meredith RF, Jones CU, Byhardt R, Horwitz EM, Ang KK, Radiation Therapy Oncology Grp. p105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: A clinical/laboratory correlative analysis of RTOG-9003. International Journal of Radiation Oncology Biology Physics. 2003 Nov;57(3) :683-692.

Vilenchik MM, Knudson AG. Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22) :12871-6.

Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single vs. double high-risk factor stratification systems for prostate cancer treated radiotherapy without androgen deprivation. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl) :S270.

Cai DP, Iyer A, Felekkis KN, Near RI, Luo ZJ, Chernoff J, Albanese C, Pestell RG, Lerner A. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Research. 2003 Oct;63(20) :6802-6808.

Schuchter L, Meropol NJ, Winer EP, Hensley ML, Somerfield MR. Amifostine and chemoradiation therapy: ASCO responds. Lancet Oncology. 2003 Oct;4(10) :593-593.

Feigenberg SJ, Hanlon AL, Horwitz EM, Pollack A. Androgen deprivation increases late morbidity in prostate cancer patients treated with 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl) :S176.

Cohen TJ, Lee K, Rutkowski LH, Strich R. Ask10p mediates the oxidative stress-induced destruction of the Saccharomyces cerevisiae C-type cyclin Ume3p/Srb11p. Eukaryotic Cell. 2003 Oct;2(5) :962-970.

Guo JT, Zhu Q, Seeger C. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons. Journal of Virology. 2003 Oct;77(20) :10769-10779.

Guo SC, Russo IH, Russo J. Difference in gene expression profile in breast epithelial cells from women with different reproductive history. International Journal of Oncology. 2003 Oct;23(4) :933-941.

Nguyen KH, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2) :377-83.

Lee HK, D'Souza WD, Yamal JM, Pollack A, Lee AK, Palmer MB, Kuban DA. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2) :355-61.

Konski A, Berkey BA, Ang KK, Fu KK. Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03. Cancer. 2003 Oct;98(7) :1497-1503.

Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. Journal of the National Cancer Institute. 2003 Oct;95(20) :1514-1521.

Russo J, Lareef AH, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. Journal of Steroid Biochemistry and Molecular Biology. 2003 Oct;87(1) :1-25.

Smith ER, Xu XX. Etiology of epithelial ovarian cancer: a cellular mechanism for the role of gonadotropins. Gynecologic Oncology. 2003 Oct;91(1) :1-2.

Diratzouian H, Freedman GM, Hanlon AL, Anderson PR. Importance of physical examination in the absence of a mammographic abnormality for detection of early stage breast cancer. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl) :S242.

Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2) :391-401.

Kruh GD. Introduction to resistance to anticancer agents. Oncogene. 2003 Oct;22(47) :7262-7264.

Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. Journal of Immunology. 2003 Oct;171(7) :3415-3425.

Li BSY, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magnetic Resonance Imaging. 2003 Oct;21(8) :923-928.

Konski AA, Sherman E, Krahn M, Bremner K, Beck J, Watkins-Bruner D, Pilepich M. Monte Carlo simulation of a Markov Model for a phase III clinical trial evaluating the addition of total androgen suppression (TAS) to radiation versus radiation alone for locally advanced prostate cancer (RTOG 86-10). Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl) :S215-6.

Freedman GM, Hanlon AL, Anderson PR. Pattern of local recurrence after conservative surgery and whole-breast radiation: implications for partial breast irradiation. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl) :S171.

Tapiero H, Townsend DM, Tew KD. Phytosterols in the prevention of human pathologies. Biomedicine & Pharmacotherapy. 2003 Oct;57(8) :321-325.

Dadke S, Chernoff J. Protein-tyrosine phosphatase 1B mediates the effects of insulin on the actin cytoskeleton in immortalized fibroblasts. Journal of Biological Chemistry. 2003 Oct;278(42) :40607-40611.

Little DJ, Kuban DA, Levy LB, Zagars GK, Pollack A. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology. 2003 Oct;62(4) :707-13.

Rosen S, Falco F. Radiofrequency stimulation of intervertebral discs. Pain Physician. 2003 Oct;6(4) :435-8.

Smith MR. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene. 2003 Oct;22(47) :7359-7368.

Zhang YZ, Zhang BH, Theele D, Litwin S, Toll E, Summers J. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proceedings of the National Academy of Sciences of the United States of America. 2003 Oct;100(21) :12372-12377.

Goldberg M, Farma J, Lampert C, Colarusso P, Coia L, Frucht H, Goosenberg E, Beard M, Weiner LM. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: A phase I report. Journal of Thoracic and Cardiovascular Surgery. 2003 Oct;126(4) :1168-1173.

Brown T, Sigurdson E, Rogatko A, Broccoli D. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line. Annals of Surgical Oncology. 2003 Oct;10(8) :910-915.

Kruh GD, Belinsky MG. The MRP family of drug efflux pumps. Oncogene. 2003 Oct;22(47) :7537-7552.

Guo Y, Chan R, Ramsey H, Li WM, Xie XD, Shelley WC, Martinez-Barbera JP, Bort B, Zaret K, Yoder M, Hromas R. The homeoprotein Hex is required for hemangioblast differentiation. Blood. 2003 Oct;102(7) :2428-2435.

Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003 Oct;22(47) :7369-7375.

Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene. 2003 Oct;22(47) :7496-7511.

Mercapide J, De Cicco RL, Castresana JS, Klein-Szanto AJP. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. International Journal of Cancer. 2003 Sep 20;106(5) :676-682.

Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood. 2003 Sep 15;102(6) :2004-13.

Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. Journal of Biological Chemistry. 2003 Sep 5;278(36) :33753-33762.

Pollack A, Hanlon AL, Movsas B, Hanks GE, Uzzo R, Horwitz EM. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1) :19-23.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C. CEP-7055: A novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Cancer Research. 2003 Sep;63(18) :5978-5991.

Breinig S, Kervinen J, Stith L, Wasson AS, Fairman R, Wlodawer A, Zdanov A, Jaffe EK. Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase. Nature Structural Biology. 2003 Sep;10(9) :757-763.

Manne S, Duhamel K, Ostroff J, Parsons S, Martini DR, Williams SE, Mee L, Sexson S, Austin J, Winkel G, Boulad F, Redd WH. Coping and the course of mother's depressive symptoms during and after pediatric bone marrow transplantation. J Am Acad Child Adolesc Psychiatry. 2003 Sep;42(9) :1055-68.

Balkwill F, Bast RC, Berek J, Chenevix-Trench G, Gore M, Hamilton T, Jacobs I, Mills G, Souhami R, Urban N, Ursulic S, Smyth J. Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust. Eur J Cancer. 2003 Sep;39(13) :1818-27.

Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, Logan T, Dutcher J, Hudes G, Dorner AJ, Slonim DK, Trepicchio WL, Burczynski ME. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Research. 2003 Sep;63(18) :6069-6075.

Ding MS, Li JS, Deng J, Fourkal E, Ma CM. Dose correlation for thoracic motion in radiation therapy of breast cancer. Medical Physics. 2003 Sep;30(9) :2520-2529.

Kaminski JM, Hanlon AL, Joon DL, Meistrich M, Hachem P, Pollack A. Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1) :24-8.

Summers J, Jilbert AR, Yang WG, Aldrich CE, Saputelli J, Litwin S, Toll E, Mason WS. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proceedings of the National Academy of Sciences of the United States of America. 2003 Sep;100(20) :11652-11659.

Adams PD, Cairns P. Induction of the estrogen receptor by ablation of DNMT1 in ER-negative breast cancer cells. Cancer Biol Ther. 2003 Sep-Oct;2(5) :557-8.

Istomina NE, Shushanov SS, Springhetti EM, Karpov VL, Krasheninnikov IA, Stevens K, Zaret KS, Singh PB, Grigoryev SA. Insulation of the chicken beta-globin chromosomal domain from a chromatin- condensing protein, MENT. Molecular and Cellular Biology. 2003 Sep;23(18) :6455-6468.

Chakravarti A, Heydon K, Wu CL, Hammond E, Pollack A, Roach M, Wolkov H, Okunieff P, Cox J, Fontanesi J, Abrams R, Pilepich M, Shipley W. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: An analysis from the Radiation Therapy Oncology Group protocol 86-10. Journal of Clinical Oncology. 2003 Sep;21(17) :3328-3334.

Patterson CE, Daley JK, Echols LA, Lane TE, Rall GF. Measles virus infection induces chemokine synthesis by neurons. Journal of Immunology. 2003 Sep;171(6) :3102-3109.

Kloeker S, Reed R, McConnell JL, Chang D, Tran K, Westphal RS, Law BK, Colbran RJ, Kamoun M, Campbell KS, Wadzinski BE. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein. Protein Expression and Purification. 2003 Sep;31(1) :19-33.

Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study. Journal of Clinical Oncology. 2003 Sep;21(17) :3194-3200.

Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol. 2003 Sep;98(9) :2078-81.

Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA. Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World J Urol. 2003 Sep;21(4) :200-8.

Freedman GM, Anderson PR, Goldstein LJ, Hanlon AL, Cianfrocca ME, Millenson MM, von Mehren M, Torosian MH, Boraas MC, Nicolaou N, Patchefsky AS, Evers K. Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer. 2003 Sep;98(5) :918-925.

Tseng M, Fang C. Screening mammography in Asian American women. American Journal of Public Health. 2003 Sep;93(9) :1378-1378.

Ko JP, Rusinek H, Jacobs EL, Babb JS, Betke M, McGuinness G, Naidich DP. Small pulmonary nodules: Volume measurement at chest CT - Phantom study. Radiology. 2003 Sep;228(3) :864-870.

Moss EG, Taylor JM. Small-interfering RNAs in the radar of the interferon system. Nature Cell Biology. 2003 Sep;5(9) :771-772.

Chang J, Taylor JM. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. Journal of Virology. 2003 Sep;77(17) :9728-9731.

Martin ES, Cesari R, Pentimalli F, Yoder K, Fishel R, Himelstein AL, Martin SE, Godwin AK, Negrini M, Croce CM. The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proceedings of the National Academy of Sciences of the United States of America. 2003 Sep;100(20) :11517-11522.

Fang CY, Miller SM, Mills M, Mangan CE, Belch R, Campbell DE, Douglas SD. The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesions. Psychooncology. 2003 Sep;12(6) :590-8.

Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Tumor expression of 4-1BB ligand sustains tumor lytic T cells. Cancer Biol Ther. 2003 Sep-Oct;2(5) :579-86.

Jacob R, Smith T, Prakasha B, Joannides T. Yttrium(90) synovectomy in the management of chronic knee arthritis: a single institution experience. Rheumatology International. 2003 Sep;23(5) :216-220.

Shalaby WS, Yeh H, Woo E, Hendren S, Corbett JT, Gray H, June CH, Shalaby SW. Development of novel substrates for tumor immunotherapy. J Control Release. 2003 Aug 28;91(1-2) :209-24.

Zhang YZ, Cheng H, Gould KL, Golemis EA, Roder H. Structure, stability, and function of hDim1 investigated by NMR, circular dichroism, and mutational analysis. Biochemistry. 2003 Aug 19;42(32) :9609-9618.

Kundrat L, Martins J, Stith L, Dunbrack RL Jr, Jaffe EK. A structural basis for half-of-the-sites metal binding revealed in Drosophila melanogaster porphobilinogen synthase. J Biol Chem. 2003 Aug 15;278(33) :31325-30.

Na X, Duan HO, Messing EM, Schoen SR, Ryan CK, di Sant'Agnese PA, Golemis EA, Wu G. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. EMBO Journal. 2003 Aug 15;22(16) :4249-4259.

Zegers MMP, Forget MA, Chernoff J, Mostov KE, ter Beest MBA, Hansen SH. Pak1 and PIX regulate contact inhibition during epithelial wound healing. EMBO Journal. 2003 Aug 15;22(16) :4155-4165.

Guo YP, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2 ',3 '- dideoxycytidine and 9 '-(2 '-phosphonylmethoxyethyl) adenine. Journal of Biological Chemistry. 2003 Aug 8;278(32) :29509-29514.

Armstrong DK, Blessing JA, Look KY, Schilder R, Nunez ER. A randomized phase II evaluation of bryostatin-1 (NSC #339555) in recurrent or persistent platinum-sensitive ovarian cancer: A Gynecologic Oncology Group Study. Investigational New Drugs. 2003 Aug;21(3) :373-377.

Capo-Chichi CD, Roland IH, Vanderveer L, Bao RD, Yamagata T, Hirai H, Cohen C, Hamilton TC, Godwin AK, Xu XX. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer Research. 2003 Aug;63(16) :4967-4977.

Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute. 2003 Aug;95(16) :1218-1226.

Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of Intergroup trial INT-0089. Journal of Clinical Oncology. 2003 Aug 1;21(15) :2912-2919.

Yamada KM, Pankov R, Cukierman E. Dimensions and dynamics in integrin function. Brazilian Journal of Medical and Biological Research. 2003 Aug;36(8) :959-966.

Prowse AH, Schultz DC, Guo S, Vanderveer L, Dangel J, Bove B, Cairns P, Daly M, Godwin AK. Identification of a splice acceptor site mutation in p16(INK4A)/p14(ARF) within a breast cancer, melanoma, neurofibroma prone kindred. Journal of Medical Genetics. 2003 Aug;40(8) :E102.

Tikhmyanova N, Coleman TR. Isoform switching of Cdc6 contributes to developmental cell cycle remodeling. Developmental Biology. 2003 Aug;260(2) :362-375.

Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, Ross DD, Funk JO. Molecular modes of action of artesunate in tumor cell lines. Molecular Pharmacology. 2003 Aug;64(2) :382-394.

Balogh GA, Russo IH, Russo J. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. International Journal of Oncology. 2003 Aug;23(2) :411-9.

Mahloogi H, Gonzalez-Guerrico AM, De Cicco RL, Bassi DE, Goodrow T, Braunewell KH, Klein-Szanto AJP. Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Research. 2003 Aug;63(16) :4997-5004.

Wang GL, Dunbrack RL. PISCES: a protein sequence culling server. Bioinformatics. 2003 Aug;19(12) :1589-1591.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Positive prostate biopsy laterality and implications for staging. Urology. 2003 Aug;62(2) :298-303.

Carbone M, Bocchetta M, Cristaudo A, Emri S, Gazdar A, Jasani B, Lednicky J, Miele L, Mutti L, Pass HI, Ramael M, Rizzo P, Testa JR, Weggen S, Yeung A. SV40 and human brain tumors. International Journal of Cancer. 2003 Aug;106(1) :140-142.

McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, Buetow KH. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003 Aug 1;63(15) :4594-601.

Katz BZ, Romer L, Miyamoto S, Volberg T, Matsumoto K, Cukierman E, Geiger B, Yamada KM. Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases. J Biol Chem. 2003 Aug 1;278(31) :29115-20.

Chism DB, Hanlon AL, Troncoso P, Al-Saleem T, Horwitz EM, Pollack A. The Gleason score shift: score four and seven years ago. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5) :1241-7.

Uzzo RG, Cairns P, Al-Saleem T, Hudes G, Haas N, Greenberg RE, Kolenko V. The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician. Urol Clin North Am. 2003 Aug;30(3) :423-36.

Gallo JM, Li SL, Guo P, Reed K, Ma JG. The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice. Cancer Research. 2003 Aug;63(16) :5114-5117.

Treat J. Weekly topotecan in the management of lung cancer. Lung Cancer. 2003 Aug;41 Suppl 4 :S27-31.

Cotteret S, Jaffer ZM, Beeser A, Chernoff J. p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol Cell Biol. 2003 Aug;23(16) :5526-39.

Gianni S, Travaglini-Allocateli C, Cutruzzolla F, Brunori M, Shastry MCR, Roder H. Parallel pathways in cytochrome c(551) folding. Journal of Molecular Biology. 2003 Jul 25;330(5) :1145-1152.

Abdollahi A, Gruver BN, Patriotis C, Hamilton TC. Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells. Biochem Biophys Res Commun. 2003 Jul 18;307(1) :188-97.

He J, Xu J, Xu XX, Hall RA. Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. Oncogene. 2003 Jul 17;22(29) :4524-30.

Taylor JC, Markham GD. Conformational dynamics of the active site loop of S-adenosylmethionine synthetase illuminated by site-directed spin labeling. Arch Biochem Biophys. 2003 Jul 15;415(2) :164-71.

Zhang L, Yang N, Katsaros D, Huang W, Park JW, Fracchioli S, Vezzani C, Rigault de la Longrais IA, Yao W, Rubin SC, Coukos G. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Cancer Res. 2003 Jul 15;63(14) :4225-31.

Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD. Transport of methotrexate, methotrexate polyglutamates, and 17 beta- estradiol 17-(beta-D-glucuronide) by ABCG2: Effects of acquired mutations at R482 on methotrexate transport. Cancer Research. 2003 Jul 15;63(14) :4048-4054.

Chen Zhijian J, Gate Laurent, Davis Warren Jr, Ile Kristina E, Tew Kenneth D. Sensitivity and fidelity of DNA microarray improved withintegration of Amplified Differential Gene Expression (ADGE). BMC Genomics. 2003 Jul 14;4(1) :28.

Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3) :755-63.

Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol. 2003 Jul 1;21(13) :2597-9.

Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003 Jul;13(3) :176-81.

Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. Journal of Urology. 2003 Jul;170(1) :166-169.

Frolov AE, Godwin AK, Favorova OO. Differential gene expression analysis by DNA microarray technology and its application in molecular oncology. Molecular Biology. 2003 Jul-Aug;37(4) :573-584.

Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA. Hepatocyte nuclear factor 4 alpha controls the development of a hepatic epithelium and liver morphogenesis. Nature Genetics. 2003 Jul;34(3) :292-296.

Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biol Ther. 2003 Jul-Aug;2(4) :446-51.

Ozols RF. Maintenance therapy in advanced ovarian cancer: Progression-free survival and clinical benefit. Journal of Clinical Oncology. 2003 Jul;21(13) :2451-2453.

Sax JK, Stoddard A, Murphy ME, Chodosh L, El-Deiry WS. Microarray expression profiling of p53-dependent transcriptional changes in an immortalized mouse embryo fibroblast cell line. Cancer Biol. Ther.. 2003 Jul-Aug;2(4) :416-430.

Fourkal E, Li JS, Ding M, Tajima T, Ma CM. Particle selection for laser-accelerated proton therapy feasibility study. Medical Physics. 2003 Jul;30(7) :1660-1670.

Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA. Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. Journal of Clinical Oncology. 2003 Jul;21(13) :2589-2596.

Trapani G, Laquintana V, Latrofa A, Ma JG, Reed K, Serra M, Biggio G, Liso G, Gallo JM. Peripheral benzodiazepine receptor ligand-melphalan conjugates for potential selective drug delivery to brain tumors. Bioconjugate Chemistry. 2003 Jul-Aug;14(4) :830-839.

Israel-Mardirosian N, Adler LP. Positron emission tomography of soft tissue sarcomas. Current Opinion in Oncology. 2003 Jul;15(4) :327-330.

Movsas B. Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol. 2003 Jul;13(3) :235-47.

von Mehren M. Recent advances in the management of gastrointestinal stromal tumors. Curr Oncol Rep. 2003 Jul;5(4) :288-94.

Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB, Burnett CB, Gaskin DJ, Marshall JL, Slater EF, Schulman KA, Meropol NJ. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer. 2003 Jul 1;98(1) :166-175.

Lee HO, Levorse JM, Shin MK. The endothelin receptor-B is required for the migration of neural crest- derived melanocyte and enteric neuron precursors. Developmental Biology. 2003 Jul 1;259(1) :162-175.

Langer CJ. The global role of irinotecan in the treatment of lung cancer: 2003 update. Oncology (Huntingt). 2003 Jul;17(7 Suppl 7) :30-40.

Murphy ME. The thousand doors that lead to death: p53-dependent repression and apoptosis. Cancer Biol Ther. 2003 Jul-Aug;2(4) :381-2.

Borgatti P, Martelli AM, Tabellini G, Bellacosa A, Capitani S, Neri LM. Threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. Journal of Cellular Physiology. 2003 Jul;196(1) :79-88.

Bellacosa A, Moss EG. RNA repair: damage control. Curr Biol. 2003 Jun 17;13(12) :R482-4.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003 Jun 15;63(12) :3403-12.

Zajaczkowski MB, Cukierman E, Galbraith CG, Yamada KM. Cell-matrix adhesions on poly(vinyl alcohol) hydrogels. Tissue Eng. 2003 Jun;9(3) :525-33.

Horwitz EM. Conformal radiotherapy with dose escalation appears safe and effective in localised prostate cancer. Cancer Treat Rev. 2003 Jun;29(3) :219-21.

Moss EG, Tang LJ. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Developmental Biology. 2003 Jun;258(2) :432-442.

Wu H, Stanley JR, Cotsarelis G. Desmoglein isotype expression in the hair follicle and its cysts correlates with type of keratinization and degree of differentiation. Journal of Investigative Dermatology. 2003 Jun;120(6) :1152-1157.

Hoffman WH, Kappler F, Passmore GG, Mehta R. Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone. Clinical Biochemistry. 2003 Jun;36(4) :269-273.

Chandra A, Dong L, Huang E, Kuban DA, O'Neill L, Rosen I, Pollack A. Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2) :436-47.

Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol. 2003 Jun;169(6) :2160-5.

Fragoso M, Seco J, Nahum AE, Verhaegen F. Incorporation of a combinatorial geometry package and improved scoring capabilities in the EGSnrc Monte Carlo code system. Medical Physics. 2003 Jun;30(6) :1076-1085.

Michael MS, Badr MZ, Badawi AF. Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator- activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells. International Journal of Molecular Medicine. 2003 Jun;11(6) :733-736.

D'Souza WD, Lee HK, Palmer MB, Smith LG, Pollack A. Is intraoperative nomogram-based overplanning of prostate implants necessary?. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2) :462-7.

Schnoll RA, James C, Malstrom M, Rothman RL, Wang H, Babb J, Miller SM, Ridge JA, Langer BM, Movsas B, Unger M, Goldberg M. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003 Summer;25(3) :214-22.

Horwitz EM, Uzzo RG, Hanlon AL, Greenberg RE, Hanks GE, Pollack A. Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. Journal of Urology. 2003 Jun;169(6) :2153-2157.

Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SD. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 2003 Jun;3(6) :565-576.

Ma JG, Li SL, Reed K, Guo P, Gallo JM. Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models. Journal of Pharmacology and Experimental Therapeutics. 2003 Jun;305(3) :833-839.

Eisenberg BL, von Mehren M. Pharmacotherapy of gastrointestinal stromal tumours. Expert Opin Pharmacother. 2003 Jun;4(6) :869-74.

Maxwell CA, Keats JJ, Crainie M, Sun XJ, Yen T, Shibuya E, Hendzel M, Chan G, Pilarski LM. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Molecular Biology of the Cell. 2003 Jun;14(6) :2262-2276.

Price RA, Chibani O, Ma CM. Shielding evaluation for IMRT implementation in an existing accelerator vault. J Appl Clin Med Phys. 2003 Summer;4(3) :231-8.

Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, Fletcher CD, Fletcher JA, Ladanyi M, Meltzer P, O'Sullivan B, Parkinson DR, Pisters PW, Saxman S, Singer S, Sundaram M, Van Oosterom AT, Verweij J, Waalen J, Weiss SW, Brennan MF. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003 Jun;9(6) :1941-56.

Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA, Beeser A, Etkin LD, Chernoff J, Earnshaw WC, Allis CD. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell. 2003 May 16;113(4) :507-517.

Pankov R, Cukierman E, Clark K, Matsumoto K, Hahn C, Poulin B, Yamada KM. Specific beta1 integrin site selectively regulates Akt/protein kinase B signaling via local activation of protein phosphatase 2A. J Biol Chem. 2003 May 16;278(20) :18671-81.

Pollack A. A call for more with a desire for less: Pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer. Journal of Clinical Oncology. 2003 May 15;21(10) :1899-1901.

Wagner Costalas J, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet. 2003 May 15;119C(1) :11-8.

Bookman MA. Developmental chemotherapy and management of recurrent ovarian cancer. J Clin Oncol. 2003 May 15;21(10 Suppl) :149s-167s.

Gate L, Lunk A, Tew KD. Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor. Biochemical Pharmacology. 2003 May 15;65(10) :1611-1622.

Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Mascillo V, d'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proceedings of the National Academy of Sciences of the United States of America. 2003 May 13;100(10) :5956-5961.

Pavlovic D, Neville DCA, Argaud O, Blumberg B, Dwek RA, Fischer WB, Zitzmann N. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proceedings of the National Academy of Sciences of the United States of America. 2003 May 13;100(10) :6104-6108.

Steel LF, Shumpert D, Trotter M, Seeholzer SH, Evans AA, London WT, Dwek R, Block TM. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics. 2003 May;3(5) :601-609.

Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspart L, Taioli E. CYP1A1 (TC)-C-3801 polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controls. International Journal of Cancer. 2003 May;104(5) :650-657.

Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, London SJ, Rannug A, Romkes M, Salagovic J, Schoket B, Gaspari L, Taioli E. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis. 2003 May;24(5) :875-882.

Ye X, Adams PD. Coordination of S-phase events and genome stability. Cell Cycle. 2003 May-Jun;2(3) :185-7.

Canutescu AA, Dunbrack RL. Cyclic coordinate descent: A robotics algorithm for protein loop closure. Protein Science. 2003 May;12(5) :963-972.

Fletcher L, Yen TJ, Muschel RJ. DNA damage in HeLa cells induced arrest at a discrete point in G(2) phase as defined by CENP-F localization. Radiation Research. 2003 May;159(5) :604-611.

Whitehead CM, Earle KA, Fetter J, Xu SM, Hartman T, Chan DC, Zhao TLM, Piazza G, Klein-Szanto AJP, Pamukcu R, Alila H, Bunn PA, Thompson WJ. Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival. Molecular Cancer Therapeutics. 2003 May;2(5) :479-488.

Garson K, Macdonald E, Dube M, Bao R, Hamilton TC, Vanderhyden BC. Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1. J Soc Gynecol Investig. 2003 May;10(4) :244-50.

Hoque MO, Lee CCR, Cairns P, Schoenberg M, Sidransky D. Genome-wide genetic characterization of bladder cancer: A comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Research. 2003 May 1;63(9) :2216-2222.

Meyers MO, Sasson AR, Sigurdson ER. Locoregional strategies for colorectal hepatic metastases. Clin Colorectal Cancer. 2003 May;3(1) :34-44.

Adler LP, Weinberg IN, Bradbury MS, Levine EA, Lesko NM, Geisinger KR, Berg WA, Freimanis RI. Method for combined FDG-PET and radiographic imaging of primary breast cancers. Breast J. 2003 May-Jun;9(3) :163-6.

Pollack A, Horwitz EM, Movsas B, Hanlon AL. Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment. Urol Clin North Am. 2003 May;30(2) :337-49.

Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med. 2003 May;18(5) :357-63.

Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML, Garte S, Haugen A, Ingelman-Sundberg M, Kihara M, Rannug A, Ryberg D, Stucker I, Sugimura H, Taioli E. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 2003 May;14(4) :339-46.

Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1) :192-8.

Armbruster BN, Etheridge KT, Broccoli D, Counter CM. Putative telomere-recruiting domain in the catalytic subunit of human telomerase. Molecular and Cellular Biology. 2003 May;23(9) :3237-3246.

Gu BH, Gates AT, Isken O, Behrens SE, Sarisky RT. Replication studies using genotype 1a subgenomic hepatitis C virus replicons. Journal of Virology. 2003 May;77(9) :5352-5359.

Moss EG. Silencing unhealthy alleles naturally. Trends in Biotechnology. 2003 May;21(5) :185-187.

Jacob R, Hawkes ND, Dallimore N, Butchart EG, Thomas GAO, Maughan TS. Squamous carcinoma in an oesophageal foregut cyst. British Journal of Radiology. 2003 May;76(905) :343-346.

Yusa S, Campbell KS. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. Journal of Immunology. 2003 May 1;170(9) :4539-4547.

Jablonski SA, Liu ST, Yen TJ. Targeting the kinetochore for mitosis-specific inhibitors. Cancer Biol Ther. 2003 May-Jun;2(3) :236-41.

Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomedicine & Pharmacotherapy. 2003 May-Jun;57(3-4) :134-144.

Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomedicine & Pharmacotherapy. 2003 May-Jun;57(3-4) :145-155.

Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Research. 2003 May;63(9) :2172-2178.

Weiner LM, Carter P. The rollercoaster ride to anti-cancer antibodies - A recent Keystone meeting highlighted the progress in developing antibody-based therapeutics for cancer. Nature Biotechnology. 2003 May;21(5) :510-511.

Cheng JD, Weiner LM. Tumors and Their Microenvironments: Tilling the Soil: Commentary re: A. M. Scott et al., A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer. Clin. Cancer Res., 9: 1639-1647, 2003. Clin Cancer Res. 2003 May;9(5) :1590-5.

Deacon K, Mistry P, Chernoff J, Blank JL, Patel R. p38 mitogen-activated protein kinase mediates cell death and p21- activated kinase mediates cell survival during chemotherapeutic drug- induced mitotic arrest. Molecular Biology of the Cell. 2003 May;14(5) :2071-2087.

Blomquist M, Karlsson M, Ma CM, Zackrisson B. Comments on 'X-ray energy choice for lung tumour irradiation depends on the density distribution of clonogenic cells'. Physics in Medicine and Biology. 2003 Apr 21;48(8) :L29-L30.

Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun. 2003 Apr 18;303(4) :1169-78.

Daniel R, Kao G, Taganov K, Greger JG, Favorova O, Merkel G, Yen TJ, Katz RA, Skalka AM. Evidence that the retroviral DNA integration process triggers an ATR- dependent DNA damage response. Proceedings of the National Academy of Sciences of the United States of America. 2003 Apr 15;100(8) :4778-4783.

Meropol NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, Rothenberg ML, Redding SW, Serdar CM, Yao B, Heard R, Rosen LS. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant. Journal of Clinical Oncology. 2003 Apr 15;21(8) :1452-1458.

Ma CM, Ding M, Li JS, Lee MC, Pawlicki T, Deng J. A comparative dosimetric study on tangential photon beams, intensity- modulated radiation therapy (IMRT) and modulated electron radiotherapy (MERT) for breast cancer treatment. Physics in Medicine and Biology. 2003 Apr 7;48(7) :909-924.

Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, Catalano PJ, Haller DG. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol. 2003 Apr-May;10(3) :213-8.

Ma GX, Fleisher L. Awareness of cancer information among Asian Americans. J Community Health. 2003 Apr;28(2) :115-30.

Hardy RR. B-cell commitment: deciding on the players. Current Opinion in Immunology. 2003 Apr;15(2) :158-65.

Mello MLS, Vidal BD, Lareef MH, Hu YF, Yang XQ, Russo J. DNA content, chromatin texture and nuclear morphology in benzo a pyrene- transformed human breast epithelial cells after microcell-mediated transfer of chromosomes 11 and 17. Cytometry Part A. 2003 Apr;52A(2) :70-76.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Urology. 2003 Apr;61(4) :754-9.

Liu ST, Hittle JC, Jablonski SA, Campbell MS, Yoda K, Yen TJ. Human CENP-I specifies localization of CENP-F, MAD1 and MAD2 to kinetochores and is essential for mitosis. Nat Cell Biol. 2003 Apr;5(4) :341-5.

Liu ST, Chan GKT, Hittle JC, Fujii G, Lees E, Yen TJ. Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores. Molecular Biology of the Cell. 2003 Apr;14(4) :1638-1651.

Pollack A, Zagars G, Antolak J, Kuban D, Rosen I. In response to Drs. Millar and Williams [letter]. Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5) :1461-2.

Jillella AP, Ustun C, Robach E, Sertkaya D, Dipiro C, Kallab AM, Brick WG, Dainer PM, Kutlar A, Townsend AR, Burgess RE. Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection. Journal of Hematotherapy & Stem Cell Research. 2003 Apr;12(2) :155-160.

Cogdill KW. Information needs and information seeking in primary care: a study of nurse practitioners. J Med Libr Assoc. 2003 Apr;91(2) :203-15.

Coukos G, Courreges MC, Benencia F. Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm. Curr Gene Ther. 2003 Apr;3(2) :113-25.

Pollack A, Cowen D, Troncoso P, Zagars GK, Von Eschenbach AC, Meistrich ML, McDonnell T. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma. Cancer. 2003 Apr 1;97(7) :1630-8.

El-Hashemite N, Zhang HB, Henske EP, Kwiatkowski DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet. 2003 Apr;361(9366) :1348-1349.

Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, Meropol NJ. Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol. 2003 Apr 1;21(7) :1301-6.

Pollack A, Grignon DJ, Heydon KH, Hammond EH, Lawton CA, Mesic JB, Fu KK, Porter AT, Abrams RA, Shipley WU. Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 2003 Apr 1;21(7) :1238-48.

Wiseman GA, Leigh BR, Erwin WD, Sparks RB, Podoloff DA, Schilder RJ, Bartlett NL, Spies SM, Grillo-Lopez AJ, Witzig TE, White CA. Radiation dosimetry results front a phase II trial of ibritumomab tiuxetan (Zevalin (TM)) radioimmunotherapy for patients with non- Hodgkin's lymphoma and mild thrombocytopenia. Cancer Biotherapy and Radiopharmaceuticals. 2003 Apr;18(2) :165-178.

Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, McCormack FX, Henske EP. Recurrent lymphangiomyomatosis after transplantation - Genetic analyses reveal a metastatic mechanism. American Journal of Respiratory and Critical Care Medicine. 2003 Apr;167(7) :976-982.

Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM, Cavalieri EL. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis. 2003 Apr;24(4) :697-702.

Taylor JM. Replication of human hepatitis delta virus: recent developments. Trends Microbiol. 2003 Apr;11(4) :185-90.

Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiology Biomarkers & Prevention. 2003 Apr;12(4) :380-383.

Hallman WK, Kipen HM, Diefenbach M, Boyd K, Kang H, Leventhal H, Wartenberg D. Symptom patterns among Gulf War registry veterans. American Journal of Public Health. 2003 Apr;93(4) :624-630.

Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res. 2003 Apr;9(4) :1517-27.

Deng Z, Chen CJ, Chamberlin M, Lu F, Blobel GA, Speicher D, Cirillo LA, Zaret KS, Lieberman PM. The CBP Bromodomain and Nucleosome Targeting Are Required for Zta-Directed Nucleosome Acetylation and Transcription Activation. Mol Cell Biol. 2003 Apr;23(8) :2633-44.

Pollack A, Horwitz EM, Movsas B. Treatment of prostate cancer with regional lymph node (N1) metastasis. Semin Radiat Oncol. 2003 Apr;13(2) :121-9.

Williams BC, Li ZX, Liu ST, Williams EV, Leung G, Yen TJ, Goldberg ML. Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions. Molecular Biology of the Cell. 2003 Apr;14(4) :1379-1391.

Engelholm LH, List K, Netzel-Arnett S, Cukierman E, Mitola DJ, Aaronson H, Kjoller L, Larsen JK, Yamada KM, Strickland DK, Holmbeck K, Dano K, Birkedal-Hansen H, Behrendt N, Bugge TH. uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion. J Cell Biol. 2003 Mar 31;160(7) :1009-15.

Lu YB, Pan ZZ, Devaux Y, Ray P. p21-activated protein kinase 4 (PAK4) interacts with the keratinocyte growth factor receptor and participates in keratinocyte growth factor- mediated inhibition of oxidant-induced cell death. Journal of Biological Chemistry. 2003 Mar 21;278(12) :10374-10380.

Selvakumaran M, Pisarcik DA, Bao R, Yeung AT, Hamilton TC. Enhanced Cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res. 2003 Mar 15;63(6) :1311-6.

Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC. Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer. Cancer Res. 2003 Mar 15;63(6) :1389-97.

Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E 3rd, Schilsky RL, Wood WC, Muss HB, Norton L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003 Mar 15;21(6) :976-83.

Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. In response to Drs. Kagan and Schulz [letter]. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4) :1151-2.

Haks MC, Belkowski SM, Ciofani M, Rhodes M, Lefebvre JM, Trop S, Hugo P, Zuniga-Pflucker JC, Wiest DL. Low activation threshold as a mechanism for ligand-independent signaling in pre-T cells. J Immunol. 2003 Mar 15;170(6) :2853-61.

Sigurdson ER. Lymph node dissection: is it diagnostic or therapeutic?. J Clin Oncol. 2003 Mar 15;21(6) :965-7.

Bock CW, Markham GD, Katz AK, Glusker JP. The arrangement of first- and second-shell water molecules in trivalent aluminum complexes: results from density functional theory and structural crystallography. Inorg Chem. 2003 Mar 10;42(5) :1538-48.

Toby GG, Gherraby W, Coleman TR, Golemis EA. A Novel RING Finger Protein, Human Enhancer of Invasion 10, Alters Mitotic Progression through Regulation of Cyclin B Levels. Mol Cell Biol. 2003 Mar;23(6) :2109-22.

Ma CM, Jiang SB, Pawlicki T, Chen Y, Li JS, Deng J, Boyer AL. A quality assurance phantom for IMRT dose verification. Physics in Medicine and Biology. 2003 Mar;48(5) :561-572.

Masny A, Daly M, Ross E, Balshem A, Gillespie D, Weil S. A training course for oncology nurses in familial cancer risk assessment: evaluation of knowledge and practice. J Cancer Educ. 2003 Spring;18(1) :20-5.

Kossenkov A, Manion FJ, Korotkov E, Moloshok TD, Ochs MF. ASAP: automated sequence annotation pipeline for web-based updating of sequence information with a local dynamic database. Bioinformatics. 2003 Mar;19(5) :675-676.

Benz C, Clark G, Conzen S, Dorn R, Fuqua S, Gralow J, Greene G, Heimann R, Hellman S, Lippman M, Rosen N, Weiner L. Consensus Statement: Expedition Inspiration Fund for Breast Cancer Research Meeting 2002. Breast Cancer Research and Treatment. 2003 Mar;78(1) :127-131.

Lee A, Rana BK, Schiffer HH, Schork NJ, Brann MR, Insel PA, Weiner DM. Distribution analysis of nonsynonymous polymorphisms within the G-protein-coupled receptor gene family. Genomics. 2003 Mar;81(3) :245-8.

Zarka TA, Han AC, Edelson MI, Rosenblum NG. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: Potential tumor suppressor role for N-cadherin. Int J Gynecol Cancer. 2003 Mar-Apr;13(2) :240-3.

Kao GD, McKenna WG, Guenther MG, Muschel RJ, Lazar MA, Yen TJ. Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. Journal of Cell Biology. 2003 Mar;160(7) :1017-1027.

Cvetkovic D, Williams SJ, Hamilton TC. Loss of Cellular Retinol-binding Protein 1 Gene Expression in Microdissected Human Ovarian Cancer. Clin Cancer Res. 2003 Mar;9(3) :1013-20.

Mohn D, Chen SW, Dias DC, Weinstein DC, Dyer MA, Sahr K, Ducker CE, Zahradka E, Keller G, Zaret KS, Gudas LJ, Baron MH. Mouse Mix gene is activated early during differentiation of ES and F9 stem cells and induces endoderm in frog embryos. Developmental Dynamics. 2003 Mar;226(3) :446-459.

Mirvish Sidney S, Haorah James, Zhou Lin, Hartman Melissa, Morris Chantey R, Clapper Marge L. N-Nitroso compounds in the gastrointestinal tract of rats and in the feces of mice with induced colitis or fed hot dogs or beef. Carcinogenesis. 2003 March 1, 2003;24(3) :595-603.

Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson BM, Hwang YT, Kerner J, Weeks J. Predictors of long-term outcomes in older breast cancer survivors: Perceptions versus patterns of care. Journal of Clinical Oncology. 2003 Mar;21(5) :855-863.

Kaminski JM, Anderson PR, Han AC, Mitra RK, Rosenblum NG, Edelson MI. Primary small cell carcinoma of the vagina. Gynecol Oncol. 2003 Mar;88(3) :451-5.

Cheon MS, Bajo M, Kim SH, Claudio JO, Stewart AK, Patterson D, Kruger WD, Kondoh H, Lubec G. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part II). Amino Acids. 2003 Mar;24(1-2) :119-25.

Schnoll RA, Bradley P, Miller SM, Unger M, Babb J, Cornfeld M. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer. 2003 Mar;39(3) :315-25.

Dumont P, Leu JIJ, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nature Genetics. 2003 Mar;33(3) :357-365.

Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC. LOT1 (PLAGL1/ZAC1), the Candidate Tumor Suppressor Gene at Chromosome 6q24-25, Is Epigenetically Regulated in Cancer. J Biol Chem. 2003 Feb 21;278(8) :6041-9.

Pinover WH, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE. Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy. Cancer. 2003 Feb 15;97(4) :1127-33.

Uzzo RG. Best therapies for prostate cancer. Bottom Line/Health.. 2003 Feb;17(2) :11-3.

Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E, Kruh GD. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Molecular Pharmacology. 2003 Feb;63(2) :351-358.

Guo JT, Pryce M, Wang X, Barrasa MI, Hu J, Seeger C. Conditional replication of duck hepatitis B virus in hepatoma cells. J Virol. 2003 Feb;77(3) :1885-93.

Norbury CC, Sigal LJ. Cross priming or direct priming: is that really the question?. Current Opinion in Immunology. 2003 Feb;15(1) :82-88.

Ehya H, Young NA. Cytologic approach to tumors of the tracheobronchial tree. Chest Surg Clin N Am. 2003 Feb;13(1) :41-62.

Stanic AK, De Silva AD, Park JJ, Sriram V, Ichikawa S, Hirabyashi Y, Hayakawa K, Van Kaer L, Brutkiewicz RR, Joyce S. Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antiqen caused by beta-D-glucosylceramide synthase deficiency. Proceedings of the National Academy of Sciences of the United States of America. 2003 Feb;100(4) :1849-1854.

Ye X, Franco AA, Santos H, Nelson DM, Kaufman PD, Adams PD. Defective s phase chromatin assembly causes DNA damage, activation of the s phase checkpoint, and s phase arrest. Mol Cell. 2003 Feb;11(2) :341-51.

Schulman KA, Stadtmauer EA, Reed SD, Glick HA, Goldstein LJ, Pines JM, Jackman JA, Suzuki S, Styler MJ, Crilley PA, Klumpp TR, Mangan KF, Glick JH. Economic analysis of conventional-dose chemotherapy compared with high- dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Bone Marrow Transplantation. 2003 Feb;31(3) :205-210.

Unger M. Endobronchial therapy of neoplasms. Chest Surg Clin N Am. 2003 Feb;13(1) :129-47.

Cohen RB. Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer. 2003 Feb;2(4) :246-51.

Brown TA, Ridge JA, Goldberg M. Gastrostomy-site tumor recurrence is not always fatal. Surg Endosc. 2003 Feb;17(2) :351.

Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the Synuclein gamma Gene CpG Island Promotes Its Aberrant Expression in Breast Carcinoma and Ovarian Carcinoma. Cancer Res. 2003 Feb 1;63(3) :664-73.

Horwitz EM, Mitra RK, Uzzo RG, Das IJ, Pinover WH, Hanlon AL, McNeeley SW, Hanks GE. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. Radiother Oncol. 2003 Feb;66(2) :173-9.

Bassi DE, Mahloogi H, De Cicco RL, Klein-Szanto A. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. American Journal of Pathology. 2003 Feb;162(2) :439-447.

Chapman JD, Bradley JD, Eary JF, Haubner R, Larson SM, Michalski JM, Okunieff PG, Strauss HW, Ung YC, Welch MJ. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2) :294-301.

Paskalev KA, Seuntjens JP, Patrocinio HJ, Podgorsak EB. Physical aspects of dynamic stereotactic radiosurgery with very small photon beams (1.5 and 3 mm in diameter). Medical Physics. 2003 Feb;30(2) :111-118.

Taioli E, Gaspari L, Benhamou S, Boffeta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Kalina I, Kremers P, Le Marchand L, London S, Rannug A, Romkes M, Schoket B, Seidegard J, Strange RC, Stucker I, To-Figueras J, Garte S. Polymorphisms in CYNA1, GSTM1, GSTT1 and lung cancer below the age of 45 years. International Journal of Epidemiology. 2003 Feb;32(1) :60-63. PMC ID:PMC 3881417.

Parsons RB, Milestone BN, Adler LP. Radiographic assessment of airway tumors. Chest Surg Clin N Am. 2003 Feb;13(1) :63-77, v-vi.

Al-Saleem TI. Re: Lin and Gray - immunoproliferative small intestinal disease. Am J Gastroenterol. 2003 Feb;98(2) :501.

Davis W Jr, Chen ZJ, Ile KE, Tew KD. Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors. Nucleic Acids Res. 2003 Feb 1;31(3) :1097-107.

Chapman JD. Single-hit mechanism of tumour cell killing by radiation. Int J Radiat Biol. 2003 Feb;79(2) :71-81.

Scott WJ. Surgical treatment of other bronchial tumors. Chest Surg Clin N Am. 2003 Feb;13(1) :111-28.

Weinberg DS. The importance of Iron deficiency anemia as a marker for gastrointestinal malignancy. Evidence-Based Gastroenterology. 2003 Feb;4(1) :11-12.

Kaminski JM, Langer CJ, Movsas B. The role of radiation therapy and chemotherapy in the management of airway tumors other than small-cell carcinoma and non-small-cell carcinoma. Chest Surg Clin N Am. 2003 Feb;13(1) :149-67.

Goldberg M, Patchefsky AF. Uncommon tumors of the tracheobronchial tree: diagnosis and management. Chest Surgery Clinics of North America. 2003 Feb;13(1) :ix-x.

Cai D, Felekkis KN, Near RI, O'Neill GM, van Seventer JM, Golemis EA, Lerner A. The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42. J Immunol. 2003 Jan 15;170(2) :969-78.

Bao KK, Wang H, Miller JK, Erie DA, Skalka AM, Wong I. Functional oligomeric state of avian sarcoma virus integrase. J Biol Chem. 2003 Jan 10;278(2) :1323-7.

Canutescu Adrian A, Shelenkov Andrew A, Dunbrack Roland L Jr. A graph-theory algorithm for rapid protein side-chain prediction. Protein Science. 2003 ;12(9) :2001-2014.

Dunbrack Roland L Jr. A scoundrel's refuge. Nature Structural Biology. 2003 ;10 :590.

Vonderheide RH, June CH. A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy. Immunol Res. 2003 ;27(2-3) :341-56.

Traut D, Goldstein LJ. Adjuvant therapy: taxanes. Journal of the National Comprehensive Cancer Network. 2003 ;1(2) :222-229.

Chen ZJ, Davis W Jr, Gate L, Tew KD. Amplified differential gene expression (ADGE). Analysing gene expression : a handbook of methods: possibilities and pitfalls. 2003 :2 v. (xxxii, 950 p.).

George Philip, Glusker Jenny P, Markham George D, Trachtman Mendel, Bock Charles W. An ab initio molecular orbital study comparing the bonding of the NH3 and the H2O in the monoammines and the monohydrates of main group and transition metal ions. Molecular Physics. 2003 ;101(15) :2451-2467.

Jaffe EK. An unusual phylogenetic variation in the metal ion binding sites of porphobilinogen synthase. Chem Biol. 2003 Jan;10(1) :25-34.

Bidaut Ghislain, Suhre Karsten, Claverie Jean-Michel, Ochs Michael F. Analysis of phylogenetic profiles using Bayesian Decomposition. Proceedings of the IEEE Bioinformatics Conference, 2nd, Stanford, CA, United States, Aug. 11-14, 2003. 2003 :480-481.

Meyers MO, Watson JC. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am. 2003 Jan;12(1) :151-63.

Patriotis PC, Querec TD, Gruver BN, Brown TR, Patriotis C. ArrayExplorer, a program in visual basic for robust and accurate filter cDNA array analysis. BioComputing : Computer Tools for Biologists. 2003 :319-329.

Hardy RR. B Lymphocyte development and biology. Fundamental Immunology. 2003 :159-194.

Moloshok TD, Datta D, Kossenkov AV, Ochs MF. Bayesian decomposition classification of the project normal data set. Methods of Microarray Data Analysis III, Papers from CAMDA '02, 3rd, Durham, NC, United States, Nov. 14-15, 2002. 2003 :211-231.

Lewis NL, Weiner LM. Biologic therapy. Clinical Practice of Hematology and Oncology : Presentation, Diagnosis, and Treatment. 2003 :376-390.

Glusker JP. Book review of Protein crystallization. Techniques, strategies and tips. A laboratory manual, edited by T.M. Bergfors. (International University Line: La Jolla, CA 1999). Crystal Growth and Design. 2003 ;3 :109.

Hudes GR. Boosting bioavailability to topotecan: What do we gain? Reply. Journal of Clinical Oncology. 2003 Jan;21(1) :177.

Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC, Engstrom PF. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the eastern cooperative oncology group. Journal of Clinical Oncology. 2003 ;21(2) :355-65.

Thallapally PK, Katz AK, Carrell HL, Desiraju GR. C-H···O hydrogen bonds in molecular complexes of 1,3,5-trinitrobenzene with some N-heterocycles. Cryst. Eng. Comm.. 2003 2003;5 :87-92.

Fischer D, Rychlewski L, Dunbrack RL Jr, Ortiz AR, Elofsson A. CAFASP3: the third critical assessment of fully automated structure prediction methods. Proteins. 2003 ;53 Suppl 6 :503-16.

Skalka AM. CSHL in the sixties: a view from the trenches. Inspiring Science: Jim Watson and the Age of DNA. 2003 :257.

Townsend D, Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics. 2003 ;3(3) :157-72.

Gervasoni JE, Wanebo HJ. Cancers of the anal canal and anal margin. Cancer Investigation. 2003 ;21(3) :452-464.

Uzzo RG. Case in point: urinary incontinence with mild obstructive symptoms. Renal & Urology News. 2003 ;2(3) :12.

Feigenberg SJ, Wolk KL, Yang CH, Morris CG, Zlotecki RA. Celecoxib to decrease urinary retention associated with prostate brachytherapy. Brachytherapy. 2003 ;2(2) :103-7.

Burke MA, Patchefsky AF. Chapter 1, Pathology. Ovarian cancer. 2003 :1-26.

Pinover WH, Iyer RV. Chapter 10, Radiation Therapy. Ovarian cancer. 2003 :132-146.

DiMascio J, Schilder RJ. Chapter 11, Early Stage Management. Ovarian cancer. 2003 :147-158.

Bookman MA. Chapter 13, Developmental Chemotherapy. Ovarian cancer. 2003 :168-193.

Lewis Nancy L, Schilder Russell J. Chapter 15, High-Dose Chemotherapy. Ovarian cancer. 2003 :213-224.

Hamilton TC, Xu X-X, Patriotis C, Salazar H. Chapter 2, Biology. Ovarian cancer. 2003 :27-38.

Blumberg BS. Chapter 2, Research organizations for discovery: two case studies. Scientific research effectiveness : the organisational dimension. 2003 :37-48.

Daly MB. Chapter 3, Epidemiology. Ovarian cancer. 2003 :39-48.

Prowse A, Frolov A, Godwin AK. Chapter 4, Genetics. Ovarian cancer. 2003 :49-82.

Bergman CA. Chapter 5, Screening. Ovarian cancer. 2003 :83-90.

Daly MB. Chapter 6, Genetic Counseling. Ovarian cancer. 2003 :91-100.

Bergman CA. Chapter 7, Diagnosis and Staging. Ovarian cancer. 2003 :101-112.

Ozols RF. Chapter 9, Primary Chemotherapy Regimens. Ovarian cancer. 2003 :119-131.

Szarka CE, Hamilton TC, Klein-Szanto AJP, Ozols RF. Chemoprevention of ovarian cancer. Ovarian cancer. 2003 :153-160.

Ma CM, Price R, McNeeley S, Chen L, Li JS, Wang L, Ding M, Fourkal E, Qin L. Clinical implementation and quality assurance for intensity modulated radiation therapy. Standards and Codes of Practice in Medical Radiation Dosimetry, Proceedings of an International Symposium, Vienna, Austria, Nov. 25-28, 2002. 2003 ;2 :369-380.

McDermott R, Hudes GR. Commentary: "Testis cancer: maintaining the high cure rate" by Derek Raghavan. Oncology. 2003 ;17 :234-5.

Manne Sharon, Duhamel Katherine, Ostroff Jamie, Parsons Susan, Martini DRichard, Williams Sharon E, Mee Laura, Sexson Sandra, Austin Jane, Winkel Gary, Boulad Farid, Redd William H. Coping and the Course of Mother's Depressive Symptoms During and After Pediatric Bone Marrow Transplantation. Journal of the American Academy of Child & Adolescent Psychiatry. 2003 ;42(9) :1055-1068.

Katz AK, Shimoni-Livny L, Navon O, Navon N, Bock CW, Glusker JP. Copper-binding motifs: Structural and theoretical aspects. Helvetica Chimica Acta. 2003 ;86(5) :1320-1338.

Guo P, Li SL, Gallo JM. Determination of carboplatin in plasma and tumor by high-performance liquid chromatography-mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2003 Jan;783(1) :43-52.

Hardy RR. Development of VH11+ B cells: a model for selection of B cells producing natural autoantibodies. Curr Dir Autoimmun. 2003 ;6 :196-211.

Biade S, Murphy ME. Differential display techniques to identify tumor suppressor gene pathways. Methods Mol Biol. 2003 ;222 :481-90.

Butts K, Daniel BL, Chen L, Bouley DM, Wansapura J, Maier SE, Dumoulin C, Watkins R. Diffusion-weighted MRI after cryosurgery of the canine prostate. Magnetic resonance imaging. J Magn Reson Imaging. 2003 Jan;17(1) :131-5.

Hamilton TC, Becker JL, Kacinski BM, Nicosia SV, Rodriquez G. Discussion: development of experimental models for ovarian cancer. Gynecol Oncol. 2003 Jan;88(1 Supplement 1) :S52-5.

Greenberg RE. Does prostate cancer represent more than one cancer?. Prostate cancer : science and clinical practice. 2003 :29-34.

Cvetkovic Dusica. Early events in ovarian oncogenesis. Reproductive Biology and Endocrinology. 2003 ;1 :No pp given.

Hirsch Fred R, Scagliotti Giorgio V, Langer Corey J, Varella-Garcia Marileila, Franklin Wilbur A. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer. 2003 2003/8;41 SUPP - 1 :29-42.

Bookman MA, Darcy KM, Clarke-Pearson D, Boothby RA, Horowitz IR. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group. Journal of Clinical Oncology. 2003 Jan;21(2) :283-290.

Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako S, Ichikawa Y, Kishi H, Godwin AK, Yoshioka M, Suga M, Matsumoto M, Wong AJ. Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer Science. 2003 Jan;94(1) :50-56.

Badawi AF, Badr MZ. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E-2 and 15-deoxy-Delta(12.14)- prostaglandin J(2) in human breast cancer and metastasis. International Journal of Cancer. 2003 Jan;103(1) :84-90.

Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest. 2003 Jan;123(1 Suppl) :272S-283S.

Blumberg BS. Foreward. Scientific research effectiveness : the organisational dimension. 2003 :1-4.

Altomare DA, Tanno S, De Rienzo A, Klein-Szanto AJ, Skele KL, Hoffman JP, Testa JR. Frequent activation of AKT2 kinase in human pancreatic carcinomas. J Cell Biochem. 2003 Jan 1;88(1) :470-6.

O'Neill GM, Catchpoole DR, Golemis EA. From correlation to causality: Microarrays, cancer, and cancer treatment. Biotechniques. 2003 :64-71.

von Mehren M. Gastrointestinal stromal tumors: A paradigm for molecularly targeted therapy. Cancer Investigation. 2003 ;21(4) :553-563.

Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest. 2003 Jan;123(1 Suppl) :221S-225S.

Maus MV, Riley JL, Kwok WW, Nepom GT, June CH. HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells. Clin Immunol. 2003 Jan;106(1) :16-22.

Ridge JA, Glisson BS, Horwitz EM, Meyers M. Head and neck tumors. Cancer management : a multidisciplinary approach : medical, surgical, & radiation oncology. 2003 :39-85.

Alan Pollack, Robert APrice. IMRT for prostate cancer. Intensity modulated radiation therapy: the state of the art. 2003 :617-630.

Chibani O, Li XA. IVBTMc, A Monte Carlo dose calculation tool for intravascular brachytherapy. Medical Physics. 2003 Jan;30(1) :44-51.

Klein AP, Kovac I, Sorant AJ, Baffoe-Bonnie A, Doan BQ, Ibay G, Lockwood E, Mandal D, Santhosh L, Weissbecker K, Woo J, Zambelli-Weiner A, Zhang J, Naiman DQ, Malley J, Bailey-Wilson JE. Importance sampling method of correction for multiple testing in affected sib-pair linkage analysis. BMC Genet. 2003 ;4 Suppl 1 :S73.

Jaffe EK. Investigations on the metal switch region of human porphobilinogen synthase. J Biol Inorg Chem. 2003 Jan;8(1-2) :176-84.

Weiner R, Ronsmans C, Dorman E, Jilo H, Muhoro A, Shulman C. Labour complications remain the most important risk factors for perinatal mortality in rural Kenya. Bulletin of the World Health Organization. 2003 ;81(8) :561-6.

Chism DB, Horwitz EM, Hanlon AL, Pinover WH, Mitra RK, Hanks GE. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1) :71-7.

Kruh Gary D. Lustrous insights into cisplatin accumulation: Copper transporters. Clinical Cancer Research. 2003 ;9(16, Pt. 1) :5807-5809.

Zaret KS. MOD special issue on the molecular mechanisms of liver and pancreas development - Preface. Mechanisms of Development. 2003 Jan;120(1) :3-3.

Rall GF. Measles virus 1998-2002: progress and controversy. Annu Rev Microbiol. 2003 ;57 :343-67.

Dumont Patrick, Della Pietra Anthony, Murphy Maureen E. Methods to study p53-repressed promoters. Methods in Molecular Biology (Totowa, NJ, United States). 2003 ;234(p53 Protocols) :111-120.

Moss Eric G. MicroRNAs. Noncoding RNAs. 2003 :99-116.

Ochs ME, Godwin AK. Microarrays in cancer: Research and applications. Biotechniques. 2003 ;34 :S4-S15.

Testa JR, Jhanwar SC. Molecular genetics of malignant mesothelioma. Pleural Disease: An International Textbook. 2003 :120-130.

von Mehren M, Adams GP, Weiner LM. Monoclonal antibody therapy for cancer. Annu Rev Med. 2003 ;54 :343-69.

Markham GD. Monovalent cation activation of inosine monophosphate dehydrogenase. Inosine monophosphate dehydrogenase : a major therapeutic target, ACS symposium series ; 839. 2003 :845-864.

Wessels A, Phelps A, Trusk TC, Davis DL, Edwards AV, Burch JB, Juraszek AL. Mouse models for cardiac conduction system development. Development of the cardiac conduction system. 2003 ;250 :44-59.

Mock V, Atkinson A, Barsevick A. NCCN 2003 cancer-related fatigue clinical practice guidelines in oncology. J. Natl. Comp. Cancer Network. 2003 ;1(3) :308-331.

Sasson AR, Wetherington RW, Hoffman JP, Ross EA, Cooper H, Meropol NJ, Freedman G, Pingpank JF, Eisenberg BL. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. International Journal of Gastrointestinal Cancer. 2003 ;34(2-3) :121-8.

von Mehren M. New therapeutic strategies for soft tissue sarcomas.. Curr. Treat. Options Oncol.. 2003 ;4(6) :441-451.

McKenna Robert J Jr, Movsas Benjamin, Shin Dong M, KhuriFadlo R. Non–small-cell lung cancer, mesothelioma, and thymoma (Chapter 7). Cancer management: a multidisciplinary approach : medical, surgical, and radiation oncology. 2003 :123-162.

Simon JA, Yen TJ. Novel approaches to screen for anticancer drugs using Saccharomyces cerevisiae. Methods Mol Biol. 2003 ;223 :555-76.

Weber RS, Berkey BA, Forastiere A, Cooper J, Maor M, Goepfert H, Morrison W, Glisson B, Trotti A, Ridge JA, Chao KSC, Peters G, Lee DJ, Leaf A, Ensley J. Outcome of salvage total laryngectomy following organ preservation therapy - The Radiation Therapy Oncology Group Trial 91-11. Archives of Otolaryngology-Head & Neck Surgery. 2003 Jan;129(1) :44-49.

Ozols Robert F, American Cancer Society. Ovarian cancer. Atlas of clinical oncology. 2003 :ix, 246.

Hamilton TC Connolly DC Daly MB Ozols RF. Ovarian cancer prevention. 39th ASCO Annual Meeting.. J. Clin. Oncol.. 2003 2003;283 .

Weinfurt KP, Sulmasy DP, Schulman KA, Meropol NJ. Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth. 2003 ;24(4) :329-44.

Ma Grace X, Fang Carolyn Y, Tan Yin, Feeley Rosemary M. Perceptions of risks of smoking among Asian Americans. Preventive Medicine: An International Journal Devoted to Practice & Theory. 2003 ;37(4) :349-355.

Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G, Griffing S, Bergsland E. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 2003 Jan;21(1) :60-65.

Schilder RJ, Brady MF, Spriggs D, Shea T. Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 2003 Jan;88(1) :3-8.

Hayakawa K, Asano M, Shinton SA, Gui M, Wen LJ, Dashoff J, Hardy RR. Positive selection of anti-Thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. Journal of Experimental Medicine. 2003 Jan;197(1) :87-99.

Levine EA, Freimanis RI, Perrier ND, Morton K, Lesko NM, Bergman S, Geisinger KR, Williams RC, Sharpe C, Zavarzin V, Weinberg IN, Stepanov PY, Beylin D, Lauckner K, Doss M, Lovelace J, Adler LP. Positron emission mammography: initial clinical results. Ann Surg Oncol. 2003 Jan-Feb;10(1) :86-91.

Engstrom PF, Clapper ML, Schnoll RA. Prevention of tobacco-related cancer. Cancer medicine 6. 2003 :383-396.

Engstrom PF, Sigurdson E, Evans AA, Pingpank JF. Primary neoplams of the liver. Cancer medicine. 2003 :1542-1553.

Battagli Cristina, Uzzo Robert G, Dulaimi Essel, Ibanez de Caceres Inmaculada, Krassenstein Rachel, Al-Saleem Tahseen, Greenberg Richard E, Cairns Paul. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Research. 2003 ;63(24) :8695-8699.

Uzzo RG, Watkins-Bruner D, Horwitz EM, Konski A, Pollack A, Engstrom PF, Kolenko V. Prostate cancer prevention: strategies and realities. Prostate cancer : science and clinical practice. 2003 :89-99.

Dadke Shrikrishna, Chernoff Jonathan. Protein-tyrosine phosphatase 1B as a potential drug target for obesity. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 2003 ;3(4) :299-304.

Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE, Huganir RL. Rapid induction of dendritic spine morphogenesis by trans-synaptic EphrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron. 2003 Jan;37(2) :263-274.

Movsas B. Recent advances and dilemmas in the radiotherapeutic management of locally advanced non-small cell lung cancer. Methods Mol Med. 2003 ;75 :489-505.

Feigenberg SJ, Movsas B. Recent avances in radiotherapeutic management of locally advanced non-small cell lung cancer. Diagn. Treat. Lung Cancer Updates. 2003 ;4(3) :1-9.

Langer C, Damsker J, Ridge A. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer. Clinical Advances in Hematology & Oncology. 2003 2003 Jul;1(7) :424-9, 440.

Karbowniczek M, Yu J, Henske EP. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures. American Journal of Pathology. 2003 ;162(2) :491-500.

Zhu Qing, Guo Ju-tao, Seeger Christoph. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. Journal of Virology. 2003 ;77(17) :9204-9210.

Frolov Andrey, Chahwan Santiago, Ochs Michael, Arnoletti Juan Pablo, Pan Zhong-Zong, Favorova Olga, Fletcher Jonathan, von Mehren Margaret, Eisenberg Burton, Godwin Andrew K. Response markers and the molecular mechanisms of action of gleevec in gastrointestinal stromal tumors. Molecular Cancer Therapeutics. 2003 ;2(8) :699-709.

Manne S. Role of coping and social support. Health psychology. 2003 ;9 :51-74.

Langer Corey J. Role of targeted therapy in non-small cell lung cancer: hype or hope?. Expert Review of Anticancer Therapy. 2003 ;3(4) :443-455.

Soares R, Guo SC, Russo J, Schmitt F. Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells. Ultrastructural Pathology. 2003 Jan-Feb;27(1) :33-39.

Diefenbach Michael A, Hamrick Natalie. Self-regulation and genetic testing: Theory, practical considerations, and interventions. The self-regulation of health and illness behaviour. 2003 :314-331.

Glisson B, McKenna R Jr, Movsas B. Small-cell lung cancer (Chapter 6). Cancer management: a multidisciplinary approach : medical, surgical, and radiation oncology. 2003 :120-122.

Schnoll RA, Lerman C. Smoking behavior and smoking cessation among head and neck cancer patients. Head and neck cancer : emerging perspectives. 2003 :185-200.

Ozols RF, Daly MB, Klein-Szanto A, Hamilton TC, Bast RC Jr, Brewer MA. Specific keynote: chemoprevention of ovarian cancer: the journey begins. Gynecol Oncol. 2003 Jan;88(1 Pt 2) :S59-66; discussion S67-70.

Torosian Michael, Biddle Veruschka R. Spirit to heal : a journey to spiritual healing with cancer. . 2003 :170, [5] p..

Langer Corey J, Hirsch Fred R, Cortes-Funes Hernan, Sawyer Stephen T, Thatcher Nick. Targeted molecular mechanisms of epoetin alfa. Lung Cancer. 2003 2003;41 SUPP - 1 :133-145.

Loehrer PJ, Ahlering TE, Pollack A. Testicular cancer. Cancer management: a multidisciplinary approach : medical, surgical, and radiation oncology. 2003 :383-402.

Blumberg BS. The NASA astrobiology institute: Early history and organization. Astrobiology. 2003 ;3(3) :463-470.

Ochs Michael F, Golemis Erica A. The biology behind gene expression: a basic tutorial. Methods of Microarray Data Analysis III, Papers from CAMDA '02, 3rd, Durham, NC, United States, Nov. 14-15, 2002. 2003 :9-24.

Langer CJ. The emerging role of gemcitabine in combination with radiation in locally advanced unresectable non-small cell lung cancer.. Clin. Lung Cancer. 2003 ;4 :S45-S49.

Neri LM, Borgatti P, Tazzari PL, Bortul R, Cappellini A, Tabellini G, Bellacosa A, Capitani S, Martelli AM. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Molecular Cancer Research. 2003 Jan;1(3) :234-246.

Pollack A. The prostate. Radiation oncology : rationale, technique, results. 2003 :629-678.

Gitterman DP, Weiner BJ, Domino ME, McKethan AN, Enthoven AC. The rise and fall of a Kaiser Permanente expansion region. Milbank Quarterly. 2003 ;81(4) :567-601.

Moore-Higgs GJ, Watkins-Bruner D, Balmer L, Johnson-Doneski J, Komarny P, Mautner B, Velji K. The role of licensed nursing personnel in radiation oncology part A: results of a descriptive study. Oncology Nursing Forum.. 2003 Jan-Feb;30(1) :51-8.

Moore-Higgs GJ, Watkins-Bruner D, Balmer L, Johnson-Doneski J, Komarny P, Mautner B, Velji K. The role of licensed nursing personnel in radiation oncology part B: integrating the ambulatory care nursing conceptual framework. Oncology Nursing Forum.. 2003 Jan-Feb;30(1) :59-64.

Liu ST, van Deursen JM, Yen TJ. The role of mitotic checkpoint in maintaining genomic stability. Current Topics in Developmental Biology. 2003 ;VOL 58, 58 :27-51.

Edwards Angela V, Davis Dorene L, Juraszek Amy L, Wessels Andy, Burch John BE. Transcriptional regulation in the mouse atrioventricular conduction system. Novartis Foundation Symposium. 2003 ;250(Development of the Cardiac Conduction System) :177-193.

Hamilton TC, Connolly DC, Nikitin AY, Garson K, Vanderhyden BC. Translational research in ovarian cancer: a must.. Int. J. Gynecol. Cancer. 2003 ;13 :1-11.

Scott WJ, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest. 2003 Suppl.;123(1) :188S-201S.

David A, Khwaja R, Hudes G. Treatments for improving survival of patients with prostate cancer. Drugs Aging. 2003 ;20(9) :683-99.

Uzzo RG, Cairns P, Leavis P, Dulin N, Horwitz EM, Pollack A, Kolenko V. Tumor resistance to apoptosis: Mechanisms of evasion and implications for radiation and chemotherapeutic strategies. Cancer immunotherapy at the crossroads : how tumors evade immunity and what can be done. 2003 :215-233.

Manne S, Markowitz A, Winawer S, Guillem J, Meropol NJ, Haller D, Jandorf L, Rakowski W, Babb J, Duncan T. Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model. Prev Med. 2003 Jan;36(1) :71-84.

Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res. 2003 Jan;9(1) :109-14.

Ruggeri Bruce A, Clapper Margie L. 1,2-Dithiol-3-thione derivatives for inhibiting angiogenesis. . 2003 20021002. :40 pp.

Zaret Kenneth S, Matsumoto Kunio, Yoshitomi Hideyuki. Methods and cell cultures for promoting organogenesis and tissue development. . 2003 20020906. :22 pp.

Testa Joseph R, Mitsuuchi Yasuhiro. Antisense molecules and small, interfering double-stranded RNA for modulation of APPL expression. . 2003 20020823. :44 pp.

2003 (449 publications)